Christine Coticchia

Christine Coticchia is currently serving as the Associate Director of Precision Medicine Early Oncology at AstraZeneca. Prior to their current role, Christine was the Director of Translational Research and Assay Development at DermBiont, Inc. Christine has also held positions as Principal Scientist at Sherlock Biosciences and Exosome Diagnostics. Christine has a Ph.D. in Tumor Biology from Georgetown University, where Christine also obtained their M.S. in Physiology and Biophysics. Their extensive research experience dates back to their time as a Graduate Student Researcher at Georgetown Lombardi Comprehensive Cancer Center.